TickerFactsScreenerDevelopers

Wave Life Sciences Ltd. (WVE) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $379.0K2013: $439.0K2014: $1.05M2015: $161.22M2016: $150.29M2017: $142.50M2018: $174.82M2019: $147.16M2020: $184.50M2021: $150.56M2022: $88.50M2023: $200.35M2024: $302.08M2025: $602.07M$602.07M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$602.07M+99.3%
2024$302.08M+50.8%
2023$200.35M+126.4%
2022$88.50M-41.2%
2021$150.56M-18.4%
2020$184.50M+25.4%
2019$147.16M-15.8%
2018$174.82M+22.7%
2017$142.50M-5.2%
2016$150.29M-6.8%
2015$161.22M+15283.6%
2014$1.05M+138.7%
2013$439.0K+15.8%
2012$379.0K—